MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited Shares 2011-2025 | VNRX
Annual Shares VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96.1 M | 81.9 M | 57.9 M | 53.8 M | 43.4 M | 39.2 M | 31.4 M | 26.4 M | 23 M | 17.7 M | 13.4 M | 10.8 M | 9.36 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 96.1 M | 9.36 M | 38.8 M |
Quarterly Shares VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110 M | 104 M | 101 M | 96.1 M | 92.4 M | 82.9 M | 82.1 M | 81.9 M | 78.3 M | 78.1 M | 63.1 M | 57.9 M | 57.5 M | 53.8 M | 53.8 M | 53.8 M | 53.2 M | 52.9 M | 50.9 M | 48.6 M | 47 M | 43.4 M | 41.2 M | 41.1 M | 39.9 M | 38.9 M | 36.2 M | 35.3 M | 32.8 M | 30 M | 27.3 M | 26.5 M | 26.5 M | 26.4 M | 26.1 M | 26.1 M | 23.5 M | 23.4 M | 19.3 M | 18.8 M | 18 M | 17.9 M | 16.5 M | 14.7 M | 13.5 M | 13.4 M | 12.2 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 8.65 M | 8.65 M | 8.65 M | 8.65 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 110 M | 8.65 M | 39.2 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
31.2 M | $ 18.98 | - | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 20.62 | 0.26 % | $ 222 M |  China |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 39.31 | - | $ 1.09 B | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 0.18 | - | $ 5.28 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
731 M | $ 230.67 | - | $ 169 B | USA |
 |
DarioHealth Corp.
DRIO
|
28.4 M | $ 10.7 | - | $ 304 M | Israel |
 |
BioNano Genomics
BNGO
|
1.27 M | $ 1.5 | - | $ 1.91 M | USA |
 |
Exact Sciences Corporation
EXAS
|
185 M | $ 101.9 | -0.03 % | $ 18.9 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
386 M | $ 67.06 | - | $ 25.9 B | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 26.49 | - | $ 801 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
53.8 M | $ 19.07 | - | $ 1.03 B | USA |
 |
Celcuity
CELC
|
39.4 M | $ 99.92 | - | $ 3.94 B | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
31.9 K | $ 3.12 | - | $ 99.5 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
181 M | $ 227.69 | - | $ 41.3 B | USA |
 |
Guardant Health
GH
|
123 M | $ 100.6 | - | $ 12.3 B | USA |
 |
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
90.6 M | $ 6.17 | - | $ 559 M | USA |
 |
ENDRA Life Sciences
NDRA
|
537 K | $ 4.76 | - | $ 2.56 M | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 7.05 | -2.35 % | $ 1.53 B | USA |
 |
National Research Corporation
NRC
|
24.5 M | $ 18.65 | - | $ 458 M | USA |
 |
Illumina
ILMN
|
159 M | $ 132.75 | - | $ 21.1 B | USA |
 |
Charles River Laboratories International
CRL
|
51.4 M | $ 201.98 | - | $ 10.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 27.39 | - | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
59.3 M | $ 7.97 | - | $ 472 M | USA |
 |
Quidel Corporation
QDEL
|
42.1 M | $ 29.3 | - | $ 1.23 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 175.49 | - | $ 19.5 B | USA |
|
Biodesix
BDSX
|
130 M | $ 6.72 | -2.04 % | $ 871 M | USA |
 |
RadNet
RDNT
|
73 M | $ 71.49 | - | $ 5.22 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
83.9 M | $ 253.07 | - | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 183.0 | - | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
82.5 M | $ 682.32 | -0.81 % | $ 56.3 B | USA |
 |
Lantheus Holdings
LNTH
|
69.2 M | $ 67.16 | - | $ 4.65 B | USA |
 |
Mettler-Toledo International
MTD
|
21.2 M | $ 1 414.32 | - | $ 30 B |  Schweiz |
 |
Agilent Technologies
A
|
304 M | $ 137.62 | - | $ 41.8 B | USA |